Source BioScience UK has acquired Cambridge Clinical Laboratories (CCL), enhancing its clinical diagnostics portfolio.

AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.

The FDA has granted approval for Innoblative Designs' IDE application, allowing it to commence a feasibility study in the US.

But while platform trials have the potential to be more effective and less expensive than traditional trials, challenges ...

Oxford Nanopore Technologies has teamed up with Cepheid to speed up infectious disease genomic analysis, blocking out recent ...

The Advanced Medical Technology Association (AdvaMed) is ‘encouraged’ by President Trump’s decision to tap the brakes and ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

APHA executive director Dr George C Benjamin has called for HHS secretary Robert F Kennedy, Jr (RFK Jr) to "resign or be ...

Eko Health has expanded into Canada with the launch of the CORE 500 Digital Stethoscope and Eko+ membership. This initiative ...

Neuranics has secured $8m in seed funding to expedite growth and commercial adoption of the TMR magnetic sensing technology.

Fasikl has reported breakthrough data showing its Felix NeuroAI wristband could offer a promising new non-invasive treatment ...

Major medtech players have seen share prices slashed over the past month, though some may be able to brave out the storm.